title: Dramatic regression of amelanotic choroidal melanoma with PDT following poor response to brachytherapy.
abstract: Photodynamic therapy (PDT) has been used for treatment of choroidal neovascular membrane from exudative macular degeneration. Other applications include treatment of some intraocular tumors, such as choroidal hemangioma, vasoproliferative tumor, and choroidal osteoma. The authors report the effect of PDT for amelanotic choroidal melanoma. A 40-year-old woman with an amelanotic choroidal melanoma of 6.5 mm thickness showed poor response to iodine brachytherapy (80 Gy apical dose) with no reduction in thickness at 16 months of follow-up. There was prominent residual tumor. The amelanotic tumor was treated with verteporfin PDT using three overlapping spots (8,600 microns), with avoidance of the optic disc using standard treatment parameters. Dramatic tumor regression over 2 months to a completely flat scar (1.3 mm thickness) was documented and remained stable at 50 months of follow-up. Amelanotic choroidal melanoma with incomplete response following conventional plaque radiotherapy can be treated with verteporfin PDT for consolidation.
authors.affiliation: Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Istanbul, Turkey. sbtuncer@yahoo.com
authors.forename: Samuray
authors.initials: S
authors.lastname: Tuncer
authors.forename: Nur
authors.initials: N
authors.lastname: Kir
authors.forename: Carol L
authors.initials: CL
authors.lastname: Shields
mesh_terms: D000328:Adult; D001918:Brachytherapy; D002830:Choroid Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D018328:Melanoma, Amelanotic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D014463:Ultrasonography; D000077362:Verteporfin; D014792:Visual Acuity / Q000502:physiology
chemical_list: D007457:Iodine Radioisotopes; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin